Detection and Evaluation of Adverse Drug Reaction Signals of Antidepressants Based on FDA Adverse Event Reporting System Database
Open Access
- 1 January 2020
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Open Journal of Depression
- Vol. 09 (02), 17-25
- https://doi.org/10.4236/ojd.2020.92002
Abstract
Background: Pre-marketing clinical research of drugs can not completely solve the safety problems in the process of wide application of drugs post-marketing, so it is necessary to re-evaluate the safety and effectiveness of drugs after marketing. Objective: To detect and analyze the adverse drug reaction (ADR) signals of Selective Serotonin Reuptake Inhibitor (SSRIs) post-marketing and provide references for clinical rational drug use. Methods: Reporting Ratio (ROR) method was used to mine the adverse reaction signals of SSRIs in the Adverse Reaction Reporting System (ARES) of the Food and Drug Administration of the United States (FDA), and the results were analyzed and evaluated. Results: Adverse Drug Events (ADEs) of fluoxetine, fluvoxamine, paroxetine, sertraline and citalopram were 40,217, 2907, 52,439, 63,849 and 42,588 cases respectively. After ROR test, there were 187 ADR signals of the five drugs, among which ADR was most prominent in psychiatric and nervous system. It mainly includes adverse reactions such as anxiety, depression, suicidal ideation, 5-HT syndrome, withdrawal syndrome and so on. Conclusion: The study based on ADR signals in the real world is helpful to evaluate the post-marking safety drugs and provide references for safety in clinical medication.Keywords
This publication has 9 references indexed in Scilit:
- OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical ApplicationsPLOS ONE, 2016
- Standardisation of the FAERS database: a systematic approach to manually recoding drug name variantsPharmacoepidemiology and Drug Safety, 2015
- Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010International Journal of Neuropsychopharmacology, 2014
- Effect of Clozapine and Olanzapine on Neutrophil Kinetics: Implications for Drug-Induced AgranulocytosisChemical Research in Toxicology, 2014
- Primary Care Providers’ Initial Treatment Decisions and Antidepressant Prescribing for Adolescent DepressionJournal of Developmental & Behavioral Pediatrics, 2014
- The Revised Warning for Antidepressants and Suicidality: Unveiling the Black Box of Statistical AnalysesAmerican Journal of Psychiatry, 2007
- Expanding the Black Box — Depression, Antidepressants, and the Risk of SuicideThe New England Journal of Medicine, 2007
- Suicidality in Pediatric Patients Treated With Antidepressant DrugsArchives of General Psychiatry, 2006
- The reporting odds ratio and its advantages over the proportional reporting ratioPharmacoepidemiology and Drug Safety, 2004